Promyelocytic leukaemia-immunoreactive neuronal intranuclear rodlets in the human brain

Neuropathology and Applied Neurobiology

Volumn 33, Issue 1, 2007, Pages 56-66

  Woulfe, J M ^a,b,c   Prichett Pejic, W ^a   Rippstein, P ^d   Munoz, D G ^e  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Class III beta tubulin; Intranuclear inclusions; Intranuclear rodlets; PML bodies; Promyelocytic leukaemia protein; Substantia nigra

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; HISTONE H4; INITIATION FACTOR 4E; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEASOME; UBIQUITIN;

AGED; ARTICLE; CELL NUCLEUS INCLUSION BODY; CELL NUCLEUS RODLET; CELL ULTRASTRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVE CELL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROMYELOCYTIC LEUKEMIA BODY; PROTEIN BINDING; PROTEIN DEGRADATION; SUBSTANTIA NIGRA; TRANSCRIPTION REGULATION;

AGED; BRAIN; FEMALE; FIXATIVES; FORMALDEHYDE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRANUCLEAR INCLUSION BODIES; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MICROSCOPY, ELECTRON; MICROSCOPY, FLUORESCENCE; NEURONS; PARAFFIN EMBEDDING; SUBSTANTIA NIGRA; TISSUE FIXATION;

EID: 33846169404     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2006.00789.x     Document Type: Article

References (32)

1. Lamond AI, Earnshaw WE. Structure and function in the nucleus. Science 1998; 2880: 547-53
2. Woulfe J, Gray D, Prichett W, Munoz D, Chretien M. Intranuclear rodlets in the substantia nigra: interactions with Marinesco bodies, ubiquitin, and promyelocytic leukemia protein. J Neuropathol Exp Neurol 2004; 63: 1200-7
3. Woulfe J, Munoz D. Tubulin immunoreactive neuronal intranuclear inclusions in the human brain. Neuropathol Appl Neurobiol 2000; 26: 161-71
4. Woulfe JM, Hammond R, Richardson B, Sooriabalan D, Parks W, Rippstein P, Munoz DG. Reduction of neuronal intranuclear rodlets immunoreactive for tubulin and glucocorticoid receptor in Alzheimer's disease. Brain Pathol 2002; 12: 300-7
5. Lamba W, Prichett W, Munoz DG, Park DS, Woulfe JM. MPTP induces intranuclear rodlet formation in midbrain dopaminergic neurons. Brain Res 2005; 1066: 86-99
6. Borden KL. Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies. Mol Cell Biol 2002; 22: 5259-69
7. Kumada S, Uchihara T, Hayashi M, Nakamura A, Kikuchi E, Mizutani T, Oda M. Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies. J Neuropathol Exp Neurol 2002; 61: 984-91
8. Lallemand-Breitenbach V, Zhu J, Puvion F, Koken M, Honore N, Doubeikovsky A, Duprez E, Pandolfi PP, Puvion E, Freemont P, de The H. Role of promyelocytic leukemia (PML) sumoylation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J Exp Med 2001; 193: 1361-71
9. Doucas V. The promyelocytic (PML) nuclear compartment and transcription control. Biochem Pharmacol 2000; 60: 1197-201
10. Boisvert FM, Kruhlak MJ, Box AK, Hendzel MJ, Bazette-Jones DP. The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body. J Cell Biol 2001; 152: 1099-106
11. Strudwick S, Borden KL. The emerging roles of translation factor eIF4E in the nucleus. Differentiation 2002; 70: 10-22
12. Villagra NT, Navascues J, Casafont I, Val-Bernal JF, Lafarga M, Berciano MT. The PML-nuclear inclusion of human supraoptic neurons: a new compartment with SUMO-1- and ubiquitin-proteasome-associated domains. Neurobiol Dis 2005; 21: 181-93
13. Villagra NT, Berciano J, Altable M, Navascues J, Casafont I, Lafarga M, Berciano MT. PML bodies in reactive sensory ganglion neurons of the Guillain-Barre syndrome. Neurobiol Dis 2004; 16: 158-68
14. Hardin JW, Spicer SS, Green WB. The paranucleolar structure, accessory body of Cajal, sex chromatin and related structures in nuclei of rat trigeminal neurons: a cytochemical and ultrastructural study. Anat Rec 1969; 164: 403-32
15. Kinderman NB, LaVelle A. A nucleolus-associated coiled body. J Neurocytol 1976; 5: 545-50
16. Lafarga M, Hervas JP, Santa-Cruz MC, Villegas J, Crespo D. The accessory body of Cajal in the neuronal nucleus. A light and electron microscopic approach. Anat Embryol (Berl) 1983; 166: 19-30
17. Carvalho T, Almeida F, Calapez A, Lafarga M, Berciano MT, Carmo-Fonseca M. The spinal muscular atrophy disease gene product, SMN: a link between snRNP biogenesis and the Cajal (coiled) body. J Cell Biol 1999; 147: 715-27
18. Matera AG. Nuclear bodies: multifaceted subdomains of the interchromatin space. Trends Cell Biol 1999; 9: 302-9
19. Sleeman JE, Lamond AI. Nuclear organization of prem-RNA splicing factors. Curr Opin Cell Biol 1999; 11: 372-7
20. Pena E, Berciano MT, Fernandez R, Ojeda JL, Lafarga M. Neuronal body size correlates with the number of nucleoli and Cajal bodies, and with the organization of the splicing machinery in rat trigeminal ganglion neurons. J Comp Neurol 2001; 430: 250-63
21. Negorev D, Maul GG. Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot. Oncogene 2001; 20: 7234-42
22. Hay RT. Role of ubiquitin-like proteins in transcriptional regulation. Ernst Schering Res Found Workshop 2006; 57: 173-92
23. Hay RT. SUMO: a history of modification. Mol Cell 2005; 18: 1-12
24. Iborra FJ, Jackson DA, Cook PR. Coupled transcription and translation within nuclei of mammalian cells. Science 2001; 293: 1139-42
25. Berciano MT, Villagra NT, Ojeda DL, Navascues J, Gomes A, Lafarga M, Carmo-Fonseca M. Oculopharyngeal muscular dystrophy-like nuclear inclusions are present in normal magnocellular neurosecretory neurons of the hypothalamus. Hum Mol Genet 2004; 13: 829-38
26. Ueda H, Goto J, Hashida H, Lin X, Oyanagi K, Kawano H, Zoghbi HY, Kanazawa I, Okazawa H. Enhanced SUMOylation in polyglutamine diseases. Biochem Biophys Res Commun 2002; 293: 307-13
27. McCampbell A, Fishbeck KH. Polyglutamine and CBP: fatal attraction? Nat Med 2001; 7: 528-30
28. Mackenzie IR, Baker M, West G, Woulfe J, Qadi N, Gass J, Cannon A, Adamson J, Feldman H, Linholm C, Melquist S, Pettman R, Sadovnick AD, Dwosh E, Whiteheart SW, Hutton M, Pickering-Brown SM. A family with taunegative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17. Brain 2006; 129: 853-67
29. McFadden K, Hamilton RL, Insalaco SJ, Lavine L, Al-Mateen M, Wang G, Wiley CA. Neuronal intranuclear inclusion disease without polyglutamine inclusions in a child. J Neuropathol Exp Neurol 2005; 64: 545-52
30. Takahashi J, Fujigasaki H, Zander C, El Hachimi KH, Stevanin G, Durr A, Lebre AS, Yvert G, Trottier Y, de The H, Hauw JJ, Duykaerts C, Brice A. PML nuclear bodies and neuronal intranuclear inclusions in polyglutamine diseases. Neurobiol Dis 2003; 13: 230-7
31. Takahashi J, Fujigasaki H, Zander C, El Hachimi KH, Stevanin G, Durr A, Lebre AS, Yvert G, Trottier Y, de The H, Hauw JJ, Duykaerts C, Brice A. Two populations of neuronal intranuclear inclusions in SCA7 differ in size and promyelocytic leukaemia protein content. Brain 2002; 125: 1534-43
32. Orr HT. Neurodegenerative disease: neuron protection agency. Nature 2004; 431: 747-8